Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Statistical | 1 | 2010 | 27 | 0.320 |
Why?
|
| Pituitary Apoplexy | 1 | 2005 | 1 | 0.230 |
Why?
|
| Pituitary Neoplasms | 1 | 2005 | 1 | 0.230 |
Why?
|
| Adenoma | 1 | 2005 | 2 | 0.230 |
Why?
|
| Humans | 13 | 2016 | 2957 | 0.220 |
Why?
|
| Neovascularization, Pathologic | 2 | 2015 | 3 | 0.180 |
Why?
|
| Female | 9 | 2016 | 1724 | 0.170 |
Why?
|
| Male | 9 | 2016 | 1860 | 0.160 |
Why?
|
| Aged | 7 | 2014 | 956 | 0.150 |
Why?
|
| Adult | 6 | 2016 | 794 | 0.150 |
Why?
|
| Middle Aged | 6 | 2014 | 792 | 0.140 |
Why?
|
| Retrospective Studies | 4 | 2016 | 167 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 2 | 2015 | 3 | 0.120 |
Why?
|
| Cryosurgery | 2 | 2013 | 2 | 0.120 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2016 | 1 | 0.120 |
Why?
|
| Scoliosis | 1 | 2016 | 2 | 0.120 |
Why?
|
| Monitoring, Intraoperative | 1 | 2016 | 4 | 0.120 |
Why?
|
| Spinal Fusion | 1 | 2016 | 10 | 0.120 |
Why?
|
| Phagocytosis | 1 | 2015 | 5 | 0.110 |
Why?
|
| Blood Platelets | 1 | 2015 | 17 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2015 | 12 | 0.110 |
Why?
|
| Signal Transduction | 1 | 2015 | 97 | 0.110 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 24 | 0.100 |
Why?
|
| Dietary Proteins | 1 | 2014 | 9 | 0.100 |
Why?
|
| Muscles | 1 | 2014 | 39 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2013 | 186 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 2 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 4 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2013 | 4 | 0.100 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2013 | 2 | 0.100 |
Why?
|
| Brachytherapy | 1 | 2012 | 1 | 0.100 |
Why?
|
| Iodine Radioisotopes | 1 | 2012 | 2 | 0.100 |
Why?
|
| Glaucoma | 1 | 2012 | 1 | 0.090 |
Why?
|
| Nerve Fibers | 1 | 2012 | 1 | 0.090 |
Why?
|
| Optic Disk | 1 | 2012 | 1 | 0.090 |
Why?
|
| Optic Nerve Diseases | 1 | 2012 | 1 | 0.090 |
Why?
|
| Retinal Ganglion Cells | 1 | 2012 | 1 | 0.090 |
Why?
|
| Tomography, Optical Coherence | 1 | 2012 | 2 | 0.090 |
Why?
|
| Algorithms | 1 | 2012 | 52 | 0.090 |
Why?
|
| Furans | 1 | 2011 | 1 | 0.090 |
Why?
|
| Gram-Positive Bacteria | 1 | 2011 | 1 | 0.090 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2011 | 1 | 0.090 |
Why?
|
| Scleroderma, Systemic | 1 | 2010 | 1 | 0.080 |
Why?
|
| Adolescent | 2 | 2016 | 247 | 0.080 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2010 | 1 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2010 | 46 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 66 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2010 | 44 | 0.080 |
Why?
|
| Cerebral Arteries | 1 | 2009 | 4 | 0.070 |
Why?
|
| ras Proteins | 1 | 2009 | 1 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2009 | 1 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2009 | 3 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 9 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 18 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 15 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 25 | 0.070 |
Why?
|
| Mutation | 1 | 2009 | 77 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 567 | 0.070 |
Why?
|
| Brain | 1 | 2009 | 202 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 2009 | 250 | 0.060 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2006 | 6 | 0.060 |
Why?
|
| Substantia Nigra | 1 | 2006 | 12 | 0.060 |
Why?
|
| Neurofibrillary Tangles | 1 | 2006 | 24 | 0.060 |
Why?
|
| Hormone Replacement Therapy | 1 | 2005 | 1 | 0.060 |
Why?
|
| Hypophysectomy | 1 | 2005 | 2 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 77 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2015 | 5 | 0.050 |
Why?
|
| Aging | 1 | 2006 | 204 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 74 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 32 | 0.050 |
Why?
|
| Disease Progression | 2 | 2012 | 99 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2010 | 3 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2016 | 9 | 0.030 |
Why?
|
| Young Adult | 1 | 2016 | 187 | 0.030 |
Why?
|
| Child | 1 | 2016 | 197 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 260 | 0.030 |
Why?
|
| Umbilical Veins | 1 | 2015 | 1 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2015 | 1 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 1 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 10 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 23 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 19 | 0.030 |
Why?
|
| Cell Communication | 1 | 2015 | 7 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 10 | 0.030 |
Why?
|
| Apoptosis | 1 | 2015 | 36 | 0.030 |
Why?
|
| Malaysia | 1 | 2014 | 1 | 0.030 |
Why?
|
| India | 1 | 2014 | 2 | 0.030 |
Why?
|
| Arm | 1 | 2014 | 2 | 0.030 |
Why?
|
| China | 1 | 2014 | 6 | 0.030 |
Why?
|
| Anthropometry | 1 | 2014 | 7 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 6 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2014 | 18 | 0.030 |
Why?
|
| Body Weight | 1 | 2014 | 34 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2014 | 64 | 0.030 |
Why?
|
| Mice | 1 | 2015 | 343 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 3 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 11 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 33 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 119 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 4 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2012 | 7 | 0.020 |
Why?
|
| Palliative Care | 1 | 2012 | 4 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 208 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 11 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 20 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 1050 | 0.020 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2011 | 2 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 12 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2011 | 9 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 19 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 12 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 47 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2010 | 1 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 1 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2010 | 1 | 0.020 |
Why?
|
| Cyclin A1 | 1 | 2010 | 1 | 0.020 |
Why?
|
| Death-Associated Protein Kinases | 1 | 2010 | 1 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 4 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2010 | 10 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2010 | 17 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 60 | 0.020 |
Why?
|
| Risk Factors | 1 | 2010 | 275 | 0.020 |
Why?
|
| Arterioles | 1 | 2009 | 2 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 4 | 0.020 |
Why?
|
| Gliosis | 1 | 2009 | 4 | 0.020 |
Why?
|
| Microcirculation | 1 | 2009 | 4 | 0.020 |
Why?
|
| Encephalitis | 1 | 2009 | 4 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2009 | 5 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 7 | 0.020 |
Why?
|
| Microglia | 1 | 2009 | 12 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2009 | 23 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 28 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2009 | 1 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2009 | 1 | 0.020 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2009 | 1 | 0.020 |
Why?
|
| Carcinoma, Large Cell | 1 | 2009 | 1 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 2 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 24 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 31 | 0.020 |
Why?
|
| Survival Rate | 1 | 2009 | 9 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 3 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 9 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 16 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2009 | 19 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 19 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 39 | 0.020 |
Why?
|
| Biomarkers | 1 | 2009 | 101 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 22 | 0.010 |
Why?
|
| Dementia | 1 | 2006 | 73 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2006 | 65 | 0.010 |
Why?
|